Table 4: Outcomes.
| Characteristics | Total (N = 252) | SSI group (N = 24) | Non SSI group (N = 228) | P value |
| Follow up period (months) | 47.33 (0.53 - 68.93) | 41.61 (1.28 - 65.81) | 47.43 (0.53 - 68.93) | P = 0.128 |
| Overall mortality | 51 (20.2%) | 10 (41.7%) | 41 (18%) | P = 0.006 |
| Overall survival | ||||
| 1 Year | 84% | 58% | 86% | P = 0.001 |
| 3 Year | 80% | 58% | 58% | |
| 5 Year | 79% | 58% | 81% | |
| Overall graft loss | 54 (21.4%) | 10 (41.7%) | 44 (19.3%) | P = 0.011 |
| Overall graft survival | ||||
| 1 Year | 82% | 58% | 85% | P = 0.003 |
| 3 Year | 78% | 58% | 80% | |
| 5 Year | 78% | 58% | 80% | |
Impact of Surgical Site Infection (SSI) on rejection rate and length of stay: We can conclude that SSI is not a
significant risk factor for rejection, however SSI does significantly prolong hospital stay.